PMVP
PMV Pharmaceuticals (PMVP)
$49
About PMV Pharmaceuticals (PMVP)
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
Details
Daily high
$1.51
Daily low
$1.46
Price at open
$1.51
52 Week High
$3.47
52 Week Low
$1.40
Market cap
77.6M
Dividend yield
0.00%
Volume
12,846
Avg. volume
229,356
P/E ratio
-1.50
PMV Pharmaceuticals News
Details
Daily high
$1.51
Daily low
$1.46
Price at open
$1.51
52 Week High
$3.47
52 Week Low
$1.40
Market cap
77.6M
Dividend yield
0.00%
Volume
12,846
Avg. volume
229,356
P/E ratio
-1.50